The significance of HPV in the follow-up period after treatment for CIN

European Journal of Gynaecological Oncology

Volumn 31, Issue 1, 2010, Pages 27-30

  Gallwas, J ^a   Ditsch, N ^a   Hillemanns, P ^a   Friese, K ^a   Thaler, C ^a   Dannecker, C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

CIN; Conization; Follow up; LEEP

Indexed keywords

ADULT; AGED; ARTICLE; BIOASSAY; CANCER RECURRENCE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION RISK; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREDICTION AND FORECASTING; PREOPERATIVE PERIOD; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; RECURRENCE; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77349104105     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pisani P., Parkin D.M., Ferlay J.: "Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden". Int. J. Cancer, 1993, 55, 891.
2. Parkin D.M., Bray F., Ferlay J., Pisani P.: "Global cancer statistics, 2002". CA Cancer J. Clin., 2005, 55, 74.
3. Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V. et al.: "International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer". N. Engl J. Med., 2003, 348, 518.
4. Agnantis N.J., Sotiriadis A., Paraskevaidis E.: "The current status of HPV DNA testing". Eur. J. Gynaecol. Oncol., 2003, 24, 351.
5. Wiley D., Masongsong E.: "Human papillomavirus: the burden of infection". Obstet. Gynecol. Surv., 2006, 61 (6 suppl. 1), S3.
6. Bekkers R.L., Massuger L.F., Bulten J., Melchers W.J.: "Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer". Rev. Med. Virol., 2004, 14, 95.
7. Cox J.T.: "Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management". Obstet. Gynecol Surv., 2006, 61 (6 suppl. 1), S15.
8. Elfgren K., Jacobs M., Walboomers J.M., Meijer C.J., Dillner J.: "Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia". Obstet. Gynecol., 2002, 100, 965.
9. Chao A., Lin C.T., Hsueh S., Chou H.H., Chang T.C., Chen M.Y., Lai C.H.: "Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization". Am. J. Obstet. Gynecol., 2004, 190, 1046.
10. Paraskevaidis E., Arbyn M., Sotiriadis A., Diakomanolis E., Martin-Hirsch P., Koliopoulos G. et al.: "The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature". Cancer Treat. Rev., 2004, 30, 205.
11. Zielinski G.D., Bais A.G., Heimerhorst T.J., Verheijen R.H., de Schipper F.A., Snijders P.J. et al.: "HPV testing and monitoring of women after treatment of CIN 3: review of the literature and metaanalysis". Obstet. Gynecol. Surv., 2004, 59, 543.
12. Alonso I., Torné A., Puig-Tintoré L.M., Esteve R., Quinto L., Campo E. et al.: "Pre- and postconisation high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3". Gynecol. Oncol., 2006, 103, 631.
13. Bornstein J., Schwartz J., Perri A., Harroch J., Zarfati D.: "Tools for post LEEP surveillance". Obstet. Gynecol. Surv., 2004, 59, 663.
14. Bar-Am A., Gamzu R., Levin I, Fainaru O., Niv J., Almog B.: "Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up". Gynecol. Oncol., 2003, 91, 149.
15. Costa S., Sideri M., Syrjänen K., Terzano P., De Nuzzo M., De Simone P. et al.: "Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer". Acta Cytol., 2000, 44, 310.
16. Herrington C.S., Evans M.F., Hallam N.F., Charnock F.M., Gray W., McGee J.D.: "Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities". Br. J. Cancer, 1995, 71, 206.
17. Melchers W.J., Bakkers J.M., Wang J., de Wilde P.C., Boonstra H., Quint W.G. et al.: "Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up". Am. J. Pathol., 1999, 155, 1473.
18. Kulmala S.M., Syrjänen S., Shabalova I., Petrovichev N., Kozachenko V., Podistov J. et al.: "Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools". J. Clin. Microbiol., 2004, 42, 2470.